Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Myovant Sciences Ltd (MYOV)

15.82   0.36 (2.33%) 10-24 22:21
Open: 15.35 Pre. Close: 15.46
High: 15.97 Low: 15.26
Volume: 355,822 Market Cap: 1,426M
Myovant Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing therapies for the treatment women’s health and endocrine diseases. Its lead product candidate is Relugolix, which is an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone (GnRH) receptor antagonist that binds to and inhibits receptors in the anterior pituitary gland. Inhibition of GnRH receptors decreases the release of the gonadotropins, luteinizing hormone (LH), and follicle-stimulating hormone (FSH), thereby decreasing the down-stream production of estrogen and progesterone by the ovaries in women and testosterone by the testes in men. The company is also advancing relugolix for the treatment of heavy menstrual bleeding associated with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. The firm is developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.997 - 16.074 16.074 - 16.143
Low: 15.074 - 15.162 15.162 - 15.242
Close: 15.673 - 15.82 15.82 - 15.953

Technical analysis

as of: 2020-10-23 4:46:56 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 22.62     One year: 26.91
Support: Support1: 13.42    Support2: 11.17
Resistance: Resistance1: 19.37    Resistance2: 23.04
Pivot: 15.50
Moving Average: MA(5): 15.49     MA(20): 15.56
MA(100): 17.92     MA(250): 14.20
MACD: MACD(12,26): -0.80     Signal(9): -0.92
Stochastic oscillator: %K(14,3): 57.41     %D(3): 55.16
RSI: RSI(14): 44.48
52-week: High: 23.04  Low: 4.14  Change(%): 276.7
Average Vol(K): 3-Month: 118919  10-Days: 84010

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MYOV has closed below upper band by 36.6%. Bollinger Bands are 55.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to MYOV's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Wed, 21 Oct 2020
Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids - GlobeNewswire

Thu, 15 Oct 2020
Buy, Sell Or Hold Myovant Sciences Ltd. (NYSE:MYOV) At $15.93? - Marketing Sentinel

Wed, 14 Oct 2020
Myovant Sciences Appoints Ryan Crowe as Vice President, Investor Relations - GlobeNewswire

Wed, 14 Oct 2020
Investors Watch-list: Myovant Sciences Ltd. (MYOV) | Armenian American Reporter - Armenian Reporter

Thu, 08 Oct 2020
Myovant Sciences Ltd. (NYSE:MYOV): Are Analysts Optimistic? - Simply Wall St

Tue, 06 Oct 2020
Hot Aspects to Watch Out: Myovant Sciences Ltd. (MYOV) - Armenian Reporter

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 90
Shares Float (M) 36
% Held by Insiders 59.91
% Held by Institutions 37.60
Shares Short (K) 1,840
Shares Short P. Month (K) 1,760

Stock Financials

EPS -2.850
EPS Est This Year -1.440
EPS Est Next Year -1.200
Book Value (p.s.) -1.490
Profit Margin
Operating Margin -693.90
Return on Assets (ttm) -76.6
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share 0.370
EBITDA (p.s.) -2.544
Qtrly Earnings Growth
Operating Cash Flow (M) -216
Levered Free Cash Flow (M) -115

Stock Valuations

PE Ratio -5.55
PEG Ratio
Price to Book value -10.62
Price to Sales 42.79
Price to Cash Flow -6.59

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.